Exiqon A/S
Announcement of management’s and closely related parties’ transactions with securities in Exiqon A/S

Exiqon A/S 

03.02.2015 15:03

Dissemination of a Adhoc News, transmitted by DGAP - a service of EQS Group
AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Copenhagen, 2015-02-03 15:03 CET (GLOBE NEWSWIRE) -- Exiqon A/S. listed on
Nasdaq OMX Copenhagen ( 'EXQ') hereby announces management's and  closely
related parties' transactions with shares and related securities in Exiqon A/S
pursuant to section 28a of the Danish Securities Trading Act as follows: 

Type of transaction:                       Buy                            
--------------------------------------------------------------------------
Type of security                           Share                          
--------------------------------------------------------------------------
Date of trade:                             3 February 2015                
--------------------------------------------------------------------------
Place of transaction:                      Nasdaq OMX Copenhagen          
--------------------------------------------------------------------------
Security Code (ISIN-kode):                 DK0060077758                   
--------------------------------------------------------------------------
                                                                          
--------------------------------------------------------------------------
Name:                                      Erik Wallden                   
--------------------------------------------------------------------------
Reason for reporting:                      Member of the Supervisory Board
--------------------------------------------------------------------------
Traded securities (no.):                                            40,000
--------------------------------------------------------------------------
Market value in DKK of traded securities:                       305,108.00
--------------------------------------------------------------------------

Additional information
Lars Kongsbak, CEO, tel. +45 4566 0888 (cell: +45 4090 2101)
Hans Henrik Chrois Christensen, CFO, tel. +45 4566 0888 (cell: +45 4090 2131)

About Exiqon (for the media)
Exiqon operates in two business areas: Exiqon Life Sciences is a leading
provider of flexible solutions for RNA analysis used by academia, biotech and
pharmaceutical companies around the world to make ground breaking discoveries
about the correlation between gene activity and the development of cancer and
other diseases. Exiqon Diagnostics develops novel molecular diagnostic tests
for early detection of cancer and treatment selection for patients based on
gene activity analysis, using the tools developed by Exiqon Life Sciences.
Exiqon is listed on the NASDAQ in Copenhagen. For more information about us,
please visit www.exiqon.com
News Source: NASDAQ OMX



03.02.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Exiqon A/S
              
               
              Denmark
Phone:        
Fax:          
E-mail:       
Internet:     
ISIN:         DK0060077758
WKN:          
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------